Lumera receives order from Harvard Medical School

May 5, 2006 – Lumera Corporation (NASDAQ:LMRA) announced that it had received a purchase order from Harvard Medical School for its beta ProteomicProcessor Biosensor instrument.

Lumera is planning to place five beta units with research organizations to demonstrate and establish new applications which take advantage of the instrument’s throughput. This purchase order is the second placement of the biosensor.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.